Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023

Patricia Yu(Centers for Disease Control and Prevention), Agam K. Rao, Riad Elmor, Kalimah Muhammad, Yon Yu(Department of Human Services)

NEJM Evidence

September 13, 2024

10.1056/evidoa2400189

Cited by 39

Related Papers

Monkeypox Outbreak — Nine States, May 2022

|MMWR Morbidity and Mortality Weekly Report|2022|309

Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events--United States, 2005-2006.

|PubMed|2008|294

Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021

|MMWR Morbidity and Mortality Weekly Report|2022|277

Nonfoodborne<i>Vibrio</i>Infections: An Important Cause of Morbidity and Mortality in the United States, 1997–2006

|Clinical Infectious Diseases|2008|206

Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022

|MMWR Morbidity and Mortality Weekly Report|2022|204